Advances in the Diagnosis and Management of Digestive System Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (31 January 2025) | Viewed by 4427

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pathology, Geisinger Medical Center, 100 N Academy Ave, Danville, PA, USA
Interests: gastrointestinal pathology; liver pathology; pancreatic pathology; molecular pathology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Although substantial advancements in the diagnosis and management of digestive system diseases have been achieved in recent years, we are still facing various challenges and dilemmas in dealing with these conditions in daily clinical practice.

To help understand and cope with these disorders, this Special Issue will focus on updates of pathogenesis, diagnosis criteria/consensus, and therapy guidelines, emphasizing efforts in tackling diagnosis and treatment difficulties.

SARS-CoV-2-induced injury in the digestive system is a significant component of COVID-19-caused mortality and mobility. Emerging microorganisms, especially drug-resistant ones, are increasingly identified in the digestive system and need special attention. Inflammatory diseases such as celiac disease, eosinophilic esophagitis/eosinophilic gastroenteritis, inflammatory bowel disease (IBD), and inflammatory bowel syndrome are still a heavy burden in healthcare, with a need for new diagnostic workups/biomarkers, therapeutic modalities, and methods evaluating therapy response. Accurate and timely diagnosis and treatment of gastroesophageal reflux disease (GERD) are still regarded as a challenging area, especially the effectiveness of preventing its progression into Barett's esophagus with currently available treatments. Inflammatory diseases of the liver, including hepatitis B virus infection and primary biliary and primary sclerosing cholangitis (PSC), have insufficient therapy responses in a significant subset of patients. The annual incidences of esophageal adenocarcinoma and colon cancer have continuously increased in the past decade(s), especially in young adults, which necessitates early diagnosis and more effective surveillance strategies and calls for more precisive management of precursor lesions in Barrett's esophagus, IBD and PSC. Molecular monitoring of minimal residual disease (MRD) in managing diagnosed GI malignancies offers predictive and prognostic value. The optimization of treatment of early GI cancers such as pT1 colon cancer is still an unmet need. Liver transplantation is the treatment of choice for liver cancer and liver failure. While acute cellular rejection is amenable to immune suppressors, chronic rejection and antibody-mediated rejection in graft survival are not well understood and remain major challenges in liver transplantation.

We invite authors to contribute knowledge in pathogenesis, diagnosis, and advanced therapies for digestive system diseases.

Dr. Jialing Huang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • digestive system
  • pathology
  • liver transplantation
  • diagnosis
  • therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

14 pages, 693 KiB  
Article
Prevalence of Functional Gastrointestinal Disorders and Associated Risk Factors Among Preschool Children in the City of Jeddah and Surrounding Areas: A Cross-Sectional Study
by Mai A. Khatib, Elham A. Aljaaly, Eram Albajri, Nahlaa A. Khalifa, Saleh Khateeb, Sarah M. Ajabnoor, Daniah Radhwan, Khawlah Aljohani and Aisha Y. Hussein
Diagnostics 2025, 15(3), 242; https://doi.org/10.3390/diagnostics15030242 - 21 Jan 2025
Viewed by 930
Abstract
Background/Objectives: Functional gastrointestinal disorders (FGIDs) affect children’s daily activities and overall performance due to gastrointestinal symptoms. This study assesses the prevalence and types of FGIDs in children living in Jeddah City and its countryside. It also examines factors that contribute to the incidence [...] Read more.
Background/Objectives: Functional gastrointestinal disorders (FGIDs) affect children’s daily activities and overall performance due to gastrointestinal symptoms. This study assesses the prevalence and types of FGIDs in children living in Jeddah City and its countryside. It also examines factors that contribute to the incidence of these disorders and their impact on children’s lifestyles. Methods: This cross-sectional study was conducted among 285 mothers of preschool children enrolled in kindergartens during the academic year 2020–2021. The Rome IV Diagnostic Questionnaire was sent out online through kindergartens to be filled out by the children’s mothers. The questionnaire assessed the prevalence of FGIDs subjectively through symptoms and their frequency. Results: Among the 285 participants, 9% (n = 27) fit the diagnostic criteria for FGIDs. Common FGIDs included functional constipation, 3.5% (n = 10); postprandial distress syndrome, 2.4% (n = 7); functional abdominal pain—not otherwise specified, 1% (n = 3); and functional epigastric pain, 0.7% (n = 2). Significant risk factors for developing FGIDs among the children in the sample included being a preterm baby (p < 0.01), being previously diagnosed with a gastrointestinal condition (p < 0.010), having a family history of diarrhea or nausea and vomiting (p < 0.001 and p < 0.01, respectively), skipping lunch at kindergarten (p < 0.01), and having pre-existing food allergies (p < 0.01). Conclusions: FGIDs were prevalent among 9% of children in Jeddah City and its countryside. Functional constipation was the most common disorder. Factors associated with FGIDs in children included preterm birth, being previously diagnosed with a GI condition, a family history of gastrointestinal conditions, irregular eating habits, and food allergies. Full article
(This article belongs to the Special Issue Advances in the Diagnosis and Management of Digestive System Diseases)
Show Figures

Figure 1

Review

Jump to: Research, Other

11 pages, 588 KiB  
Review
A Multidisciplinary Approach to the Classification and Management of Intestinal Failure: Knowledge in Progress
by Sol Ramírez-Ochoa, Luis Asdrúval Zepeda-Gutiérrez, Mauricio Alfredo Ambriz-Alarcón, Berenice Vicente-Hernández, Gabino Cervantes-Guevara, Karla D. Castro Campos, Karla Valencia-López, Gabino Cervantes-Pérez, Mariana Ruiz-León, Francisco Javier Hernández-Mora, Tania Elizabeth Cervantes-Nápoles, María Elena Flores-Villavicencio, Sandra O. Sánchez-Sánchez and Enrique Cervantes-Pérez
Diagnostics 2024, 14(19), 2114; https://doi.org/10.3390/diagnostics14192114 - 24 Sep 2024
Viewed by 1664
Abstract
Intestinal failure (IF) is a debilitating condition characterized by the insufficient function of the gastrointestinal tract to absorb nutrients and fluids essential for life. This review consolidates recent advancements and challenges in managing IF among adult and pediatric populations, highlighting differences in etiology, [...] Read more.
Intestinal failure (IF) is a debilitating condition characterized by the insufficient function of the gastrointestinal tract to absorb nutrients and fluids essential for life. This review consolidates recent advancements and challenges in managing IF among adult and pediatric populations, highlighting differences in etiology, management, and outcomes. Over the recent years, significant strides have been made in the nutritional and medical management of IF, significantly reducing mortality rates and improving the quality of life for patients. Key advancements include the development and availability of glucagon-like peptide-2 (GLP-2) analogs, improved formulations of parenteral nutrition, and the establishment of specialized interdisciplinary centers. Short bowel syndrome (SBS) remains the predominant cause of IF globally. The pediatric segment is increasingly surviving into adulthood, presenting unique long-term management challenges that differ from adult-onset IF. These include the need for tailored nutritional support, management of IF-associated liver disease, and addressing growth and neurodevelopmental outcomes. The therapeutic landscape for IF continues to evolve with the development of new treatment modalities and better understanding of the condition’s pathophysiology. However, disparities in treatment outcomes between children and adults suggest the need for age-specific management strategies. This review underscores the importance of a nuanced approach to IF, incorporating advancements in medical science with a deep understanding of the distinct needs. Full article
(This article belongs to the Special Issue Advances in the Diagnosis and Management of Digestive System Diseases)
Show Figures

Figure 1

Other

Jump to: Research, Review

10 pages, 2168 KiB  
Case Report
Androgen-Induced, β-Catenin-Activated Hepatocellular Adenomatosis with Spontaneous External Rupture
by Jialing Huang, Towhid Ali, David M. Feldman and Neil D. Theise
Diagnostics 2024, 14(14), 1473; https://doi.org/10.3390/diagnostics14141473 - 9 Jul 2024
Cited by 1 | Viewed by 1209
Abstract
Androgens have long been recognized as oncogenic agents. They can induce both benign and malignant hepatocellular neoplasms, including hepatocellular adenoma (HCA) and hepatocellular carcinoma, though the underlying mechanisms remain unclear. Androgen-induced liver tumors are most often solitary and clinically silent. Herein, we reported [...] Read more.
Androgens have long been recognized as oncogenic agents. They can induce both benign and malignant hepatocellular neoplasms, including hepatocellular adenoma (HCA) and hepatocellular carcinoma, though the underlying mechanisms remain unclear. Androgen-induced liver tumors are most often solitary and clinically silent. Herein, we reported an androgen-induced HCA complicated by spontaneous rupture. The patient was a 24-year-old male presenting with fatigue, diminished libido, radiology-diagnosed hepatocellular adenomatosis for 3 years, and sudden-onset, severe, sharp, constant abdominal pain for one day. He used Aveed (testosterone undecanoate injection) from age 17 and completely stopped one year before his presentation. A physical exam showed touch pain and voluntary guarding in the right upper quadrant of the abdomen. An abdominal CT angiogram demonstrated multiple probable HCAs, with active hemorrhage of the largest one (6.6 × 6.2 × 5.1 cm) accompanied by large-volume hemoperitoneum. After being stabilized by a massive transfusion protocol and interventional embolization, he underwent a percutaneous liver core biopsy. The biopsy specimen displayed atypical hepatocytes forming dense cords and pseudoglands. The lesional cells diffusely stained β-catenin in nuclei and glutamine synthetase in cytoplasm. Compared to normal hepatocytes from control tissue, the tumor cells were positive for nuclear AR (androgen receptor) expression but had no increased EZH2 (Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit) protein expression. The case indicated that androgen-induced hepatocellular neoplasms should be included in the differential diagnosis of acute abdomen. Full article
(This article belongs to the Special Issue Advances in the Diagnosis and Management of Digestive System Diseases)
Show Figures

Figure 1

Back to TopTop